Rio P. Juni

Empagliflozin and Dapagliflozin Reduce ROS Generation and Restore NO Bioavailability in Tumor Necrosis Factor α-Stimulated Human Coronary Arterial Endothelial Cells

Laween Uthman, Anna Homayr, Rio P. Juni et al. · Cellular Physiology and Biochemistry · 2019 · 208 citations · Full text

Medicine, Cardiology, Pharmacology +17

Cardiac Microvascular Endothelial Enhancement of Cardiomyocyte Function Is Impaired by Inflammation and Restored by Empagliflozin

Rio P. Juni, Diederik W.D. Kuster, Max Goebel et al. · JACC Basic to Translational Science · 2019 · 199 citations · Full text

Medicine, Cardiology, Pharmacology +17

Empagliflozin restores chronic kidney disease–induced impairment of endothelial regulation of cardiomyocyte relaxation and contraction

Rio P. Juni, Rushd Al‐Shama, Diederik W.D. Kuster et al. · Kidney International · 2020 · 77 citations · Full text

Medicine, Cardiology, Pharmacology +14

Therapeutic Delivery of miR-148a Suppresses Ventricular Dilation in Heart Failure

Andrea Raso, Ellen Dirkx, Leonne E. Philippen et al. · Molecular Therapy · 2018 · 70 citations · Full text

Medicine, Cardiology, Molecular Medicine +15

FGF23 impairs peripheral microvascular function in renal failure

Melissa Verkaik, Rio P. Juni, Ellen P. M. van Loon et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2018 · 48 citations · Full text

Medicine, Cardiology, Nephrology +11